BRD4 and gastric cancer: Next, we examined BRD4 expression in tissue samples from gastric precancerous lesions (PL/36), early GC (EGC/36), and advanced GC (AGC /82), as well as noncancerous gastric mucosa (NG/20) using immunohistochemistry (Fig. 1b).